These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 18687587

  • 1. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P, Benkhoucha M, Weber MS, Zamvil SS, Santiago-Raber ML, Lalive PH.
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [Abstract] [Full Text] [Related]

  • 2. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice.
    Izui S, Higaki M, Morrow D, Merino R.
    Eur J Immunol; 1988 Jun; 18(6):911-5. PubMed ID: 3260184
    [Abstract] [Full Text] [Related]

  • 3. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
    Wofsy D.
    J Immunol; 1986 Jun 15; 136(12):4554-60. PubMed ID: 3086436
    [Abstract] [Full Text] [Related]

  • 4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 15; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 5. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W, Tsukamoto K, Ohtsuji M, Lin Q, Ida A, Kodera S, Ohtsuji N, Nakamura K, Tsurui H, Kinoshita K, Nishimura H, Shirai T, Hirose S.
    Int Immunol; 2007 Feb 15; 19(2):175-83. PubMed ID: 17189592
    [Abstract] [Full Text] [Related]

  • 6. Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus.
    Amano H, Amano E, Santiago-Raber ML, Moll T, Martinez-Soria E, Fossati-Jimack L, Iwamoto M, Rozzo SJ, Kotzin BL, Izui S.
    Arthritis Rheum; 2005 Sep 15; 52(9):2790-8. PubMed ID: 16142734
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov 15; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 8. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.
    Int Immunol; 2006 Apr 15; 18(4):537-44. PubMed ID: 16481342
    [Abstract] [Full Text] [Related]

  • 9. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E, Lee Y, Park N, Cho C, Yim YN, Kim J, Kim YS, Kim D, Shin MK, Hong MC, Bae H.
    Lupus; 2007 Apr 15; 16(5):335-41. PubMed ID: 17576735
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
    Zhang L, Bertucci AM, Smith KA, Xu L, Datta SK.
    Arthritis Rheum; 2007 Dec 15; 56(12):4132-41. PubMed ID: 18050205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML, Amano H, Amano E, Baudino L, Otani M, Lin Q, Nimmerjahn F, Verbeek JS, Ravetch JV, Takasaki Y, Hirose S, Izui S.
    Arthritis Rheum; 2009 Aug 15; 60(8):2408-17. PubMed ID: 19644866
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Spatial and motor abilities during the course of autoimmune disease in (NZW x BXSB)F1 lupus-prone mice.
    Arabo A, Costa O, Tron F, Caston J.
    Behav Brain Res; 2005 Nov 30; 165(1):126-37. PubMed ID: 16168499
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
    Hudson CA, Cao L, Kasten-Jolly J, Kirkwood JN, Lawrence DA.
    J Toxicol Environ Health A; 2003 May 23; 66(10):895-918. PubMed ID: 12825236
    [Abstract] [Full Text] [Related]

  • 18. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L, Ito S, Ishii KJ, Klinman DM.
    Arthritis Rheum; 2005 Feb 23; 52(2):651-8. PubMed ID: 15692999
    [Abstract] [Full Text] [Related]

  • 19. The effect of the phytoestrogen coumestrol on the NZB/W F1 murine model of systemic lupus.
    Schoenroth LJ, Hart DA, Pollard KM, Fritzler MJ.
    J Autoimmun; 2004 Dec 23; 23(4):323-32. PubMed ID: 15571926
    [Abstract] [Full Text] [Related]

  • 20. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D.
    J Soc Biol; 2002 Dec 23; 196(1):19-21. PubMed ID: 12134628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.